Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
Rajiv Khanna(QIMR Berghofer Medical Research Institute), Denis J. Moss(The University of Queensland), Scott R. Burrows(Australian National University), E Kieff(QIMR Berghofer Medical Research Institute), T B Sculley(QIMR Berghofer Medical Research Institute), Catherine Jacob(QIMR Berghofer Medical Research Institute), I S Misko(QIMR Berghofer Medical Research Institute), Michael G. Kurilla(QIMR Berghofer Medical Research Institute)
Cited by 391
Related Papers
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332
A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity
|Immunity|2003|323
Estimating the global burden of Epstein–Barr virus-related cancers
|Journal of Cancer Research and Clinical Oncology|2021|313
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.
|The Journal of Experimental Medicine|1994|281